- Faculty of Medicine - Institute of Laboratory Medicine, University Hospital of LMU Munich
- Start date
- as soon as possible
- Application deadline
- 20 May 2021
As one of Europe’s leading research universities, Ludwig-MaximiliansUniversität (LMU) in Munich is committed to the highest international standards of excellence in research and teaching. Building on its more than 500-year-long tradition, it offers a broad spectrum that covers all areas of knowledge within its 18 Faculties, ranging from the humanities, law, economics and social sciences, to medicine and the natural sciences.
The Faculty of Medicine invites applications for a Professorship (W2) (fixed term for 6 years) of Personalised Drug Therapy and Drug Safety funded by the Stiftung Patient & klinische Pharmazie commencing as soon as possible.
The professorship will be located at the Institute of Laboratory Medicine, University Hospital of LMU Munich.
The professorship shall implement leading-edge projects for the translation of personalised drug therapy safety in clinical practice at the interface of clinical-pharmaceutical and biomedical research. The research focus is on the investigation and establishment of indicators for therapeutic monitoring and verification of therapeutic effects, using biochemical, genetic, cell-biological, physiological or functional techniques, preferably with a cardiovascular focus. The research should be aimed at implementing its findings in inpatient care, as well as at assessing the effect and benefit for the patient. The endowed professorship should support teaching in the field of drug therapy safety across disciplines and is responsible for the management and further development of the already successfully established, structured PhD programme in Clinical Pharmacy.
Applicants should have experience in leading a research group and in successfully acquiring external funding. Preferably, the applicant has experience in the management and development of structured doctoral programmes. Moreover, applicants should have experience in the clinical implementation of personalised drug therapy and in experimental preclinical/biomedical research. Ideally, applicants should have a proven track record in the field of cellular and molecular mechanisms of cardiovascular disease and/or (patho)physiological processes.
LMU Munich seeks to appoint a highly qualified junior academic to this professorship and, therefore, especially encourages early-career scholars to apply. Prerequisites for this position are a university degree and a doctoral degree or a comparable specific qualification. With an excellent record in research and teaching to date, prospective candidates will have demonstrated the potential for an outstanding academic career.
The position is a fixed-term professorship for the duration of six years. A conversion to an indefinite position (tenure track) is not possible.
LMU Munich makes a point of providing newly appointed professors with various types of support, such as welcoming services and assistance for dual career couples.
LMU Munich is an equal opportunity employer. The University continues to be very successful in increasing the number of female faculty members and strongly encourages applications from female candidates. LMU Munich intends to enhance the diversity of its faculty members.
People with disabilities who are equally as qualified as other applicants will receive preferential treatment.
Please submit your application (curriculum vitae, scientific career, references, certificates, a list of publications and lectures, external funds) as well as a short application form (see http://www.med. uni-muenchen.de) to the Dean of the Faculty of Medicine, LudwigMaximilians-Universität München, Bavariaring 19, 80336 Munich, Germany, no later than May 20th 2021.